GlassScriptPhysician profile
Jason R Jensen
NPI 1871715367
$21,210.90
in general payments reported to CMS, 2019-2025
20 companies · $5,687 in 2025
The $5,687 reported for 2025 was more than what 93% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $845 · 2020: $799 · 2021: $645 · 2022: $1,416 · 2023: $7,231 · 2024: $4,589 · 2025: $5,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $3,778 · Education: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,560.03 |
| Travel and Lodging | $3,777.92 |
| Education | $1,169.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $6,071.94 | 2019-2024 | Senza, Omnia, Vyrsa V1 |
| Abbott Laboratories | $4,920.78 | 2021-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $3,156.14 | 2019-2025 | General - Pain Management, Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $2,685.65 | 2023-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $1,156.79 | 2025 | Senza, Omnia, Corridor |
| Foundation Fusion Solutions, LLC | $933.17 | 2022-2025 | |
| Vertos Medical, INC. | $751.62 | 2023-2024 | Mild Device Kit |
| Stryker Corporation | $313.01 | 2024-2025 | Spinejack, Mild Device Kit, Optablate |
| Saluda Medical Americas, INC. | $266.98 | 2024 | Evoke |
| Bausch & Lomb Americas INC. | $145.36 | 2024-2025 | Xiidra |
| Medtronic, INC. | $138.80 | 2023 | Intellis Adaptivestim |
| Ethicon US, LLC | $122.39 | 2022 | |
| Nuvasive, INC. | $108.55 | 2019 | |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Allergan, INC. | $82.16 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $68.69 | 2019 | |
| Collegium Pharmaceutical, INC. | $63.77 | 2023 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.44 | 2023 | Relistor |
| Averitas Pharma INC. | $46.00 | 2023 | Qutenza |
| Depuy Synthes Sales INC. | $32.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.